Purchase Order 75D30124P19919
Award Date 9/9/24
Potential Completion Date 9/9/24
Potential Value $160K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Centers for Disease Control and Prevention awarded a $1,852.50 firm fixed price purchase order to Illumina, Inc. for an Illumina NextSeq Sequencer. As the sole manufacturer of this proprietary sequencing instrument, Illumina will deliver one NextSeq Sequencer to support genomic analysis activities at the CDC's Pittsburgh location. No set-aside provision was applied to this acquisition of an Illumina sequencing system, which will aid the CDC in disease detection, surveillance, and research...
- The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents, for the procurement of a NEXTSEQ 1000 SEQUENCING SYSTEM. The total potential value of the award is $205,800.00 with a completion date of August 23, 2021. Illumina has a history of providing sequencing equipment, consumables, and services to federal agencies such as the National...
- This is a $273,825 firm fixed price contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc. for an AOA 6293 NextSeq 500 gene sequencing system. The contract has no set-aside designation. Illumina is a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis. They have provided sequencing systems and related products to support research and diagnostics across various federal agencies, including the NIH, USDA, and VA....
- This federal contract award to Illumina, Inc. is for the procurement of a MiSeq System, a genetic sequencing platform and associated consumables and services. The $93,529 firm fixed price contract was awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh. The contract does not have a set-aside designation. Illumina is a leading manufacturer of advanced genetic sequencing instruments, reagents, and bioinformatics software. The company has been awarded multiple federal...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents, for the provision of an ILLUMINA NS 1000 INSTRUMENT. The potential value of this award is $205,800.00. Illumina has previously received prime federal contract awards from various agencies like the NIH, CDC, USDA, and VA to provide a range of genomic sequencing systems, consumables, and...
- This firm fixed-price federal contract award to Illumina, Inc. is for the provision of laboratory equipment, valued at $205,800.00. The contract was issued by the Centers for Disease Control and Prevention (CDC) Pittsburgh and has a ceiling value of $205,800.00. The contract does not have a set-aside designation. Based on Illumina's background as a manufacturer and provider of sequencing and genomic analysis solutions, the equipment being provided likely includes various NextSeq, NovaSeq, MiSeq,...
- This is a $94,050.00 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and analysis instruments and reagents. The award is for an Illumina MiSeq sequencing system and does not have a set-aside designation. Illumina has a history of providing sequencing equipment and services to support research and diagnostics across various federal agencies, including the National Institutes of Health, Department of...
- The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order contract to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $22,376.85 contract is for the provision of an ISEQ 100 SYSTEM, with a completion date of March 1, 2026. This award does not have a set-aside designation. Illumina has previously received prime federal contracts from agencies such as the NIH,...
- This is a firm fixed price purchase order contract awarded to Illumina, Inc., a manufacturer of genomic sequencing and analysis products, by the Centers for Disease Control and Prevention (CDC). The $90,260.40 contract does not have a set-aside designation. Illumina has previously provided sequencing instruments, reagents, and related services to support genomic research and diagnostics across various federal agencies. This award appears to be for the provision of Illumina's sequencing...
- This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract is for the provision of a NextSeq sequencing system and has a ceiling value of $230,845.58. The contract has a period of performance ending on September 30, 2024. Illumina has previously been awarded prime contracts and subcontracts by various federal agencies, including the National Institutes...